Companies are using CRISPR to engineer viruses to kill antibiotic resistant bacteria. At least two approaches may be in clinical trials within 18 months.
[ Lire plus… ]
Short link : https://lmc.today/6qsx
Companies are using CRISPR to engineer viruses to kill antibiotic resistant bacteria. At least two approaches may be in clinical trials within 18 months.
[ Lire plus… ]